News

On March 28, 2026, a one-day scientific conference on the prevention of haemoglobinopathies took place at the Amphitheatre “Phaedon Fessas” of Laiko General Hospital of

We are delighted to share that HELIOS Working Group 4 (WG4) has published a new article in Blood & Global Health titled “Mapping Expertise and

As HELIOS moves into the second half of the project, we are pleased to announce the opening of several leadership and coordination positions within the

We are pleased to announce that members of the HELIOS consortium have published a new peer-reviewed research article in the journal HemaSphere. This publication reflects

We’re excited to announce the launch of the HELIOS Survey: Building Gender-Inclusive Research Cultures! The survey aims to collect information on institutional and national practices

We are pleased to announce that HELIOS CA22119 will be actively participating in the upcoming ASCAT Conference 2025, taking place at ExCeL London. 📅 On

Exciting News: Abstract PB3837 Accepted at EHA 2025! We’re proud to announce that our abstract, PB3837, has been accepted for presentation at the European Hematology

NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease In a landmark decision, the National Health Service (NHS) in England has approved the use

In March 2023,  the first HELIOS-funded Short-Term Scientific Mission (STSM) was completed. The project was carried out by HELIOS member Maria Xenophontos from the Cyprus

WG5 – Dissemination and outreach has just published the HELIOS website that you can visit here!